120 related articles for article (PubMed ID: 11159686)
1. Stereoselective effects of the enantiomers of a new local anaesthetic, IQB-9302, on a human cardiac potassium channel (Kv1.5).
González T; Longobardo M; Caballero R; Delpón E; Sinisterra JV; Tamargo J; Valenzuela C
Br J Pharmacol; 2001 Jan; 132(2):385-92. PubMed ID: 11159686
[TBL] [Abstract][Full Text] [Related]
2. Effects of bupivacaine and a novel local anesthetic, IQB-9302, on human cardiac K+ channels.
González T; Longobardo M; Caballero R; Delpón E; Tamargo J; Valenzuela C
J Pharmacol Exp Ther; 2001 Feb; 296(2):573-83. PubMed ID: 11160646
[TBL] [Abstract][Full Text] [Related]
3. Structural determinants of potency and stereoselective block of hKv1.5 channels induced by local anesthetics.
Longobardo M; Delpón E; Caballero R; Tamargo J; Valenzuela C
Mol Pharmacol; 1998 Jul; 54(1):162-9. PubMed ID: 9658202
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers.
Valenzuela C; Delpón E; Tamkun MM; Tamargo J; Snyders DJ
Biophys J; 1995 Aug; 69(2):418-27. PubMed ID: 8527655
[TBL] [Abstract][Full Text] [Related]
5. Bupivacaine effects on hKv1.5 channels are dependent on extracellular pH.
Longobardo M; González T; Caballero R; Delpón E; Tamargo J; Valenzuela C
Br J Pharmacol; 2001 Sep; 134(2):359-69. PubMed ID: 11564654
[TBL] [Abstract][Full Text] [Related]
6. Kvbeta1.3 reduces the degree of stereoselective bupivacaine block of Kv1.5 channels.
Arias C; Guizy M; David M; Marzian S; González T; Decher N; Valenzuela C
Anesthesiology; 2007 Oct; 107(4):641-51. PubMed ID: 17893461
[TBL] [Abstract][Full Text] [Related]
7. Molecular determinants of stereoselective bupivacaine block of hKv1.5 channels.
Franqueza L; Longobardo M; Vicente J; Delpón E; Tamkun MM; Tamargo J; Snyders DJ; Valenzuela C
Circ Res; 1997 Dec; 81(6):1053-64. PubMed ID: 9400387
[TBL] [Abstract][Full Text] [Related]
8. Effects of a quaternary bupivacaine derivative on delayed rectifier K(+) currents.
Longobardo M; González T; Navarro-Polanco R; Caballero R; Delpón E; Tamargo J; Snyders DJ; Tamkun MM; Valenzuela C
Br J Pharmacol; 2000 May; 130(2):391-401. PubMed ID: 10807678
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes.
Valenzuela C; Snyders DJ; Bennett PB; Tamargo J; Hondeghem LM
Circulation; 1995 Nov; 92(10):3014-24. PubMed ID: 7586272
[TBL] [Abstract][Full Text] [Related]
10. Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5.
Perchenet L; Hilfiger L; Mizrahi J; Clément-Chomienne O
J Pharmacol Exp Ther; 2001 Sep; 298(3):1108-19. PubMed ID: 11504808
[TBL] [Abstract][Full Text] [Related]
11. Characterization of mibefradil block of the human heart delayed rectifier hKv1.5.
Perchenet L; Clément-Chomienne O
J Pharmacol Exp Ther; 2000 Nov; 295(2):771-8. PubMed ID: 11046117
[TBL] [Abstract][Full Text] [Related]
12. Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: stereoselective bupivacaine block.
González T; Arias C; Caballero R; Moreno I; Delpón E; Tamargo J; Valenzuela C
Br J Pharmacol; 2002 Dec; 137(8):1269-79. PubMed ID: 12466236
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective interactions of the enantiomers of chromanol 293B with human voltage-gated potassium channels.
Yang IC; Scherz MW; Bahinski A; Bennett PB; Murray KT
J Pharmacol Exp Ther; 2000 Sep; 294(3):955-62. PubMed ID: 10945846
[TBL] [Abstract][Full Text] [Related]
14. Effect of descarboethoxyloratadine, the major metabolite of loratadine, on the human cardiac potassium channel Kv1.5.
Caballero R; Delpón E; Valenzuela C; Longobardo M; Franqueza L; Tamargo J
Br J Pharmacol; 1997 Nov; 122(5):796-8. PubMed ID: 9384491
[TBL] [Abstract][Full Text] [Related]
15. Assembly with the Kvbeta1.3 subunit modulates drug block of hKv1.5 channels.
González T; Navarro-Polanco R; Arias C; Caballero R; Moreno I; Delpón E; Tamargo J; Tamkun MM; Valenzuela C
Mol Pharmacol; 2002 Dec; 62(6):1456-63. PubMed ID: 12435814
[TBL] [Abstract][Full Text] [Related]
16. Effects of ropivacaine on a potassium channel (hKv1.5) cloned from human ventricle.
Valenzuela C; Delpón E; Franqueza L; Gay P; Snyders DJ; Tamargo J
Anesthesiology; 1997 Mar; 86(3):718-28. PubMed ID: 9066339
[TBL] [Abstract][Full Text] [Related]
17. Amide local anesthetics potently inhibit the human tandem pore domain background K+ channel TASK-2 (KCNK5).
Kindler CH; Paul M; Zou H; Liu C; Winegar BD; Gray AT; Yost CS
J Pharmacol Exp Ther; 2003 Jul; 306(1):84-92. PubMed ID: 12660311
[TBL] [Abstract][Full Text] [Related]
18. Papaverine blocks hKv1.5 channel current and human atrial ultrarapid delayed rectifier K+ currents.
Choe H; Lee YK; Lee YT; Choe H; Ko SH; Joo CU; Kim MH; Kim GS; Eun JS; Kim JH; Chae SW; Kwak YG
J Pharmacol Exp Ther; 2003 Feb; 304(2):706-12. PubMed ID: 12538825
[TBL] [Abstract][Full Text] [Related]
19. Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac kv1.5 channels.
Caballero R; Valenzuela C; Longobardo M; Tamargo J; Delpón E
Br J Pharmacol; 1999 Nov; 128(5):1071-81. PubMed ID: 10556945
[TBL] [Abstract][Full Text] [Related]
20. Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels.
Franqueza L; Valenzuela C; Delpón E; Longobardo M; Caballero R; Tamargo J
Br J Pharmacol; 1998 Nov; 125(5):969-78. PubMed ID: 9846634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
